Live-Attenuated Tetravalent Dengue Vaccine Development at Mahidol University

Article Sidebar

PDF
Published: Feb 19, 2016
DOI: https://doi.org/10.31524/bkkmedj.2016.02.017
Keywords:
dengue, vaccine, live attenuation

Main Article Content

Sutee Yoksan, MD, PhD

Abstract

Dengue virus (DENV) is a mosquito- borne flavivirus endemic to tropical and subtropical regions of the world. Four antigenically related serotypes of DENV circulate in nature. While 2/3 of these infections are unapparent and non-symptom-atic, clinical manifestations range from a self-limited febrile illness to a potentially fatal disease characterized by hemorrhage and/or shock

Article Details

How to Cite
1.
Yoksan S. Live-Attenuated Tetravalent Dengue Vaccine Development at Mahidol University. BKK Med J [Internet]. 2016 Feb. 19 [cited 2024 Apr. 18];11(1):85. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/221504
Issue
Vol. 11 (2016): February
Section
Speacial Feature

This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.